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Highlights：
 EPB41L4A and LEP gene polymorphisms are associated with antipsychotic-induced QTc interval prolongation (AIQTIP) in Han Chinese which is an important contribution to understanding the biology of AIQTIP.
 First explore quantitative associations between SNPs of metabolism-related genes and AIQTIP in patients with schizophrenia.
 Study the different effects of different antipsychotics on QTc interval in Chinese patients with schizophrenia. 
Introduction
Schizophrenia is a chronic and serious psychiatric disorder, and the life expectancy of patients with schizophrenia is 15 years shorter than that of the general population (Hjorthoj et al., 2017) . Compared with the general population, the overall mortality rate of patients with schizophrenia is higher, and the risk of death from cardiovascular disease is especially increased (Druss, 2018) . This may be related to metabolic changes caused by increased risks of obesity, weight gain, dyslipidemia and type 2 diabetes of patients with schizophrenia, some of which may be relevant to antipsychotic drugs Polcwiartek et al., 2016) . It is well known that antipsychotics could induce QT interval prolongation (Beach et al., 2013) , and antipsychotic-induced QT interval prolongation (AIQTIP) is associated with an increased risk of arrhythmias. QT interval prolongation is a high risk for ventricular tachycardia or torsade de pointes (TDP), if it not be managed immediately, which can eventually deteriorate into fatal ventricular fibrillation or even sudden cardiac death (SCD) (Antoniou et al., 2017; Nielsen et al., 2011) .
QT interval measured on the electrocardiogram (ECG) represents ventricular depolarization and repolarization. Because the heart rate affects the duration of the QT interval, the formula of Bazett (QTc = QT/RR 0.5 ) is usually used to correct the QT interval for heart rate (Luo et al., 2004) . Normally, for adult men the average heart rate-corrected QT interval (QTc) is approximately 410 to 430 ms, and for adult women 420 to 430 ms. A prolonged QTc is usually defined as＞450ms for men and＞ 470ms for women (Rijnbeek et al., 2014) . QTc interval above 500ms is associated with a twofold to threefold increase in the risk of TDP (Cohagan and Brandis, 2019) .
Therefore, this threshold has been advised for drug discontinuation for both men and women (Becker et al., 1998) .
QTc interval prolongation can be divided into congenital and acquired. The congenital QTc interval prolongation is caused by Mendelian genetic disorders, known as long QTc syndromes (Niemeijer et al., 2015) . Acquired QTc interval prolongation is related to many factors, such as age, gender, electrolyte disturbance, bradycardia, coronary heart disease, heart failure, drug and genetic susceptibility, etc (Drew et al., 2010) . Female is a well known risk factor (Khan et al., 2019) . The susceptibility of acquired QTc interval prolongation to pharmacological therapy can be affected by genetic variation (Strauss et al., 2017) . About 30-40% of QTc interval variation is heritable (Hong et al., 2001) . Acquired QTc interval prolongation is mainly caused by drugs. A series of drugs can lead to QTc interval prolongation, including cardiac drugs, typical and atypical antipsychotics, antidepressants, antibiotics, etc (Roden, 2016) . AIQTIP has long been recognized (Takeuchi et al., 2015) . In recent years, the prolongation of QTc interval has become a problem that we must pay more attention to when prescribing psychotropic drugs (Nielsen et al., 2011) .
QTc interval prolongation is one of the main reasons for drugs to withdraw from the market, although they may be beneficial to some patients but not harmful to all patients (Niemeijer et al., 2015) . Identifying the genetic factors related to AIQTIP may reduce the risk of AIQTIP, and avoid unnecessary withdrawal of some effective drugs from the market.
With the development of pharmacogenetics, a number of genes related to QTc interval prolongation induced by antipsychotics have been identified. Most of these studies are based on candidate gene approach, such as KCNH2 (Atalar et al., 2010; Corponi et al., 2019) , CACNA1C (Fabbri et al., 2017) , NOS1AP (Corponi et al., 2019) , KCNE1 (Weeke et al., 2014) , NDRG4 (Watanabe et al., 2017) , PLN (Watanabe et al., 2017) , ABCB1 (Corponi et al., 2019; Suzuki et al., 2014) , ACN9 (Weeke et al., 2014) .
Among these genes, NOS1AP (Corponi et al., 2019) , KCNH2 (Atalar et al., 2010; Corponi et al., 2019) , ABCB1 (Corponi et al., 2019; Suzuki et al., 2014) are frequently replicated for variations. Up to now, there are two genome-wide association studies (GWAS) of AIQTP, which found associations on SLC22A23 (Aberg et al., 2012) , CERKL, SLCO3A1, BRUNOL4, NRG3, NUBPL and PALLD genes polymorphisms (Volpi et al., 2009 ). As the GWAS study requires a very large sample size to obtain sufficient power, candidate gene approach enabled us to use increased statistical power to perform association study for prioritized genes.
Up to now it is still unclear whether specific genetic polymorphisms mediate AIQTIP. These studies that identified genes associated with AIQTIP are mostly of Caucasians, and many results are inconsistent (Fabbri et al., 2017; Spellmann et al., 2018) . There are few studies on Asian population, up to now, there is only one study on 66 Japanese patients with schizophrenia (Suzuki et al., 2014) , and there is no study on Chinese population. And this kind of research mainly focuses on genes related to cardiac ion channels (Atalar et al., 2010; Corponi et al., 2019) (Fabbri et al., 2017; Weeke et al., 2014) , cardiac signal conduction (Corponi et al., 2019) , cardiac relaxation and contraction (Watanabe et al., 2017) and enzymes involved in pharmacokinetics of drugs (Llerena et al., 2004) . As cardiovascular disease is the leading cause of death for schizophrenia patients (Druss, 2018) , which is closely associated with metabolic changes of schizophrenia patients (Polcwiartek et al., 2016) , at present, there is no research to explore the relationship between AIQTIP and metabolism-related genes.
This study is the first to explore changes in QTc intervals in Chinese patients with schizophrenia after receiving single atypical antipsychotics, and this study is also the first to study the genes related to AIQTIP in Chinese patients suffered from schizophrenia. In this study, our objective is to identify the metabolism-related genes associated with AIQTIP in Chinese patients suffered from schizophrenia by analyzing quantitative associations between single nucleotide polymorphisms (SNPs) of candidate genes and AIQTIP.
Materials and methods

Subjects and design：
In this study, we collected a total of 280 patients suffered from schizophrenia and 112 cases met the inclusion criteria, including 34 first-episode drug-naïve patients (FENP). All the patients were unrelated Han Chinese hospitalized in the Tianjin Mental Health Center.
The entry criteria for this study were as follows： (1) 
Genotyping and SNP selection
Peripheral venous blood was extracted with 5ml EDTA anticoagulant tube, plasma was stored in refrigerator at 4℃, and genomic DNA was extracted within one
week. All samples in this study were deposited and processed in the Molecular and The association between the selected SNPs and several phenotypes was analyzed by using linear regression model in PLINK, where the changes of QTc were used as phenotypes for the quantitative trait locus analysis.
We used PLINK to perform pairwise gene-gene interaction analysis (epistasis) among selected gene SNPs in all patients, male patients and female patients. All P values were 2 tailed, and the significant level was 0.05.
Results
Sample and baseline characteristics
In total, we collected 280 hospitalized patients suffered from schizophrenia, and 112 cases met the inclusion criteria, including 34 FENP. Thus, 48 patients were treated with olanzapine, 36 with risperidone, 5 with clozapine, 11 with quetiapine, 5 with aripiprazole and 7 with palipiperone.
The clinical characteristics of subjects were shown in Table 2 .
Changes of QTc interval after 4 weeks of treatment
Compared with the baseline, the QTc interval was generally prolonged after 4 weeks of treatment, and the difference was statistically significant (t = 2.748, P=0.07).
After 4 weeks of treatment, the QTc interval of female patients was longer than that of the baseline, and the difference was statistically significant (t = 2.460, P=0.016). For male patients, the QTc interval was also prolonged after 4 weeks of treatment, but there was no statistical significance compared with the baseline (t = 1.494, P=0.143).
There was no significant difference in the prolongation of QTc interval between male and female patients before and after treatment (t = 0.334, P=0.739).
Comparisons of QTc interval at baseline and at week 4 were shown in Table 3 .
Changes of QTc interval after different antipsychotic drugs treatment
Antipsychotics showed different effects on the prolongation of QTc. Quetiapine had the most distinct effect on QTc interval prolongation, followed by olanzapine and risperidone. After 4 weeks of treatment, the QTc interval of aripiprazole and clozapine group was shorter than that of baseline, and the difference was not statistically significant. After 4 weeks of treatment, the QTc interval had no difference compared with baseline in paliperidone treatment group.
A gender-specific abnormal QTc interval (male > 450 ms, female > 470 ms) was observed in four male patients with olanzapine and one female patient with risperidone after 4 weeks of treatment.
After 4 weeks of treatment with AAPDs, two patients had a QTc interval＞ 500ms, including one male patient taking olanzapine with a QTc of 518ms and another female patient taking risperidone with a QTc of 504 ms. For the treatment of the two patients, the drugs were stopped immediately and switched to other antipsychotic drugs. Administered drugs and QTc interval at baseline and at week 4 were shown in table 3.
Genotypes
Candidate genes and SNPs genotyped in this study are showed in table 1. All the SNPs we analyzed are in Hardy-Weinberg equilibrium. Table 4 shows the results of quantitative association analysis of candidate genes and QTc changes in phenotypes at 4 weeks. In all subjects, we found a significant association between the EPB41L4A SNP rs7732687 and AIQTIP (P=0.042). In male patients, we also found a significant association between the EPB41L4A SNP rs7732687 and AIQTIP (P=0.034). In female patients, the LEP SNP rs7799039 was significantly associated with AIQTIP (P=0.004). For LEPR (rs1137101), BDNF (rs6265), NRXN3 (rs7141420), FTO (rs9939609), FTO (rs1558902), MC4R
(rs6567160), MC4R (rs489693), and COMT (rs4680) no significant associations could be found between AIQTIP and SNPs. 
Discussion
AIQTIP is believed to be affected by many factors, including drugs and genes.
Several risk factors combined may contribute to AIQTIP. Some gene variations will increase the risk of AIQTIP. With the development of pharmacogenetics, many genes associated with AIQTIP have been discovered. However, so far, no gene test of AIQTIP has been approved for clinical application. Although there have been many important discoveries about genes associated with AIQTIP, but the most consistent and reproducible findings are with NOS1AP (Aberg et al., 2012; Corponi et al., 2019) , KCNH2 (Atalar et al., 2010; Corponi et al., 2019) , ABCB1 (Corponi et al., 2019; Suzuki et al., 2014) genes. Moreover, the results of many studies are inconsistent (Fabbri et al., 2017; Spellmann et al., 2018) , because of different admission criteria, different ethnic groups, or poor statistical efficiency.
In the past, most researches have mainly focused on genes associated with cardiac ion channels (Atalar et al., 2010; Corponi et al., 2019) , (Fabbri et al., 2017; Weeke et al., 2014) , cardiac diastolic and systolic function (Watanabe et al., 2017) , cardiac signal transduction (Corponi et al., 2019) , and enzymes related to pharmacokinetics of drugs (Llerena et al., 2004) . As the main cause of death in patients with schizophrenia is cardiovascular disease (Druss, 2018) . This is closely related to metabolic changes caused by increased risks of dyslipidemia, weight gain, obesity, type 2 diabetes of schizophrenic patients, and some of which may be related to the use of antipsychotic drugs (Polcwiartek et al., 2016) . Up to now, there is no study on the association between AIQTIP and metabolism-related genes. In this study, we analyzed the association between 10 SNPs in 8 candidate genes closely related to metabolism and AIQTIP by using candidate gene approach. The 10 SNPs in 8 candidate genes closely related to metabolism were selected, respectively: rs1137101 (LEPR), rs7732687 (EPB41L4A), rs7799039 (LEP), rs6265 (BDNF), rs7141420 (NRXN3), rs9939609 (FTO), rs1558902 (FTO), rs6567160 (MC4R), rs489693 (MC4R), and rs4680 (COMT).
Prolongation of QTc interval induced by antipsychotic drugs is well known (Beach et al., 2013) . In this study, we found that after 4 weeks of AAPD treatment, the QTc interval was generally prolonged as compared with the baseline in all subjects.
After grouping according to gender, the QTc interval of female patients was also prolonged after 4 weeks of treatment. For male patients, the QTc interval was also longer than that of the baseline after 4 weeks of treatment, but there was no statistical significance compared with the baseline. This is consistent with the research results of Suzuki Y et al (Suzuki et al., 2013) . And it is well known that female gender is a risk factor for drug induced QTc interval prolongation (Khan et al., 2019) . Women are more sensitive to QTc interval prolonging medications than men (Ravens, 2018; Trojak et al., 2009 ). In addition, different antipsychotics showed different effects on the prolongation of QTc interval, of which quetiapine has the most distinct effect. And this is consistent with the meta-analysis results of Leucht et al (Leucht et al., 2013) . A gender-specific abnormal QTc interval (male > 450 ms, female > 470 ms) was observed in four male patients with olanzapine and one female patient with risperidone after 4 weeks of treatment. After 4 weeks of treatment with AAPDs, two patients' QTc intervals were greater than 500ms, one of whom was male patient taking olanzapine, and QTc was 518ms, the other one was female patient taking risperidone, and QTc was 504 ms. For the treatment of these two patients, we immediately stopped the drugs and switched to other antipsychotic drugs.
This study showed that after 4 weeks of AAPD treatment, the QTc interval was generally prolonged in all subjects, and more seriously, the QTc interval of individual patients were greater than 500ms, which is associated with a twofold to threefold increase in the risk of torsade de pointes (Cohagan and Brandis, 2019) . This result reminded us that even in the short-term treatment of AAPD therapy, we should pay close attention to AIQTIP in patients suffered from schizophrenia, especially in female patients.
In our study, SNP in EPB41L4A yielded significant association for AIQTIP.
EPB41L4A-AS1 is located in the 5q22.2 region, which is closely related to tumorigenesis because of frequent DNA deletions. It is well known that EPB41L4A-AS1 inhibits tumor proliferation and is associated with many solid tumors (Xu et al., 2016) , such as breast cancer (Xu et al., 2016) , non-small cell lung cancer (Shu et al., 2018) , hepatocellular carcinoma , colorectal cancer (He et al., 2019) . However, its role in cancer is unclear (Liao et al., 2019) . At present, no research has found that EPB4A is related to AIQTIP. A basic research has found that EPB4A is related to regulating glycolysis and glutamine hydrolysis (Liao et al., 2019) .
It has been reported that glycolysis is increased and QTc interval is prolonged in patients with right ventricular hypertrophy (Piao et al., 2010) . Therefore, EPB4A may prolong QTc interval by affecting glycolysis. In this study, we tested 1 SNP of EPB41L4A gene, which is rs7732687. Our research showed that the EPB41L4A SNP rs7732687 was significantly associated with AIQTIP (P=0.042). The QTc intervals of patients carrying EPB41L4A rs7732687 TT genotype were significantly longer than that of patients with TC and CC genotypes after 4 weeks of AAPD therapy. Therefore the T allele increased the risk of AIQTIP.
After grouping according to gender, SNP in EPB41L4A yielded significant association for AIQTIP in male patients, and SNP in LEP yielded significant association for AIQTIP in female patients. In our study, the LEP quantitative association with AIQTIP was first discovered. LEP encoding leptin on chromosome 7
is associated with the presence of SNPs, which can regulate the concentration of this adipokine in blood circulation. As the most studied SNP, rs7799039 is located in the promoter region of LEP gene (de Faria et al., 2017) . In our study, we tested one SNP of LEP gene, that is rs7799039. LEP is associated with blood pressure, obesity, and sympathetic hyperactivity. Leptin regulates food intake by suppressing appetite. The high level of Leptin in serum is related to the development of inflammation, insulin resistance, and oxidative stress (Katsiki et al., 2018) . These may be related to the occurrence and development of cardiovascular diseases including QTc interval prolongation and arrhythmia.
As a result, for LEPR (rs1137101), BDNF (rs6265), NRXN3 (rs7141420), FTO Therefore, further association research is needed to confirm our discovery.
In conclusion, atypical antipsychotic drugs can significantly prolong QTc interval in schizophrenic patients in short-term therapy, and there are gender differences. Different drugs have different effects on QTc interval prolongation. The EPB41L4A SNP rs7732687 is associated with AIQTIP in male patients, and the LEP SNP rs7799039 is associated with AIQTIP in female patients. 
